Specific Marker of Sézary Cells Detection of Extracellular Vimentin as a SC5 mAb Represents a Unique Tool for the

Bensussan and Anne Marie-CardineCapdevielle, Laurence Conraux, Pascual Ferrara, Armand Delphine Huet, Martine Bagot, Denis Loyaux, Joelhttp://www.jimmunol.org/content/176/1/652J Immunol€2006; 176:652-659; ;Referenceshttp://www.jimmunol.org/content/176/1/652.full#ref-list-1This article cites 36 articles, 10 of which you can access for free at: Subscriptionshttp://jimmunol.org/subscriptionsInformation about subscribing to The Journal of Immunology is online at: Permissionshttp://www.aai.org/ji/copyright.htmlSubmit copyright permission requests at: Email Alertshttp://jimmunol.org/cgi/alerts/etocReceive free email-alerts when new articles cite this article. Sign up at:

[1]  F. Fox,et al.  Pathogenesis of cutaneous T-cell lymphoma: implications for the use of recombinant cytokines and photopheresis. , 1997, Clinical and experimental immunology.

[2]  H. Kerl,et al.  EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. , 1997, Blood.

[3]  M. Nikolova,et al.  Identification of Cell Surface Molecules Characterizing Human Cutaneous T-cell Lymphomas , 2002, Leukemia & lymphoma.

[4]  R. Gascoyne,et al.  Aberrant expression of T-plastin in Sezary cells. , 2003, Cancer research.

[5]  M. Bagot,et al.  CD158k/KIR3DL2 is a new phenotypic marker of Sezary cells: relevance for the diagnosis and follow-up of Sezary syndrome. , 2004, The Journal of investigative dermatology.

[6]  L. Old,et al.  Cancer/testis (CT) antigens - a new link between gametogenesis and cancer. , 2001, Cancer immunity.

[7]  D. Green,et al.  Dicing with death: dissecting the components of the apoptosis machinery. , 1994, Trends in biochemical sciences.

[8]  K. Bennett,et al.  Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement. , 1996, Immunity.

[9]  N. Dang,et al.  Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood. , 2001, American journal of clinical pathology.

[10]  S. Whittaker,et al.  Amplification and overexpression of JUNB is associated with primary cutaneous T-cell lymphomas. , 2003, Blood.

[11]  A. Kotini,et al.  Immunohistochemical expression of vimentin and secretory component antigens in endometrial hyperplasia and neoplasia. , 2002, European journal of gynaecological oncology.

[12]  Y. Tokura,et al.  CD7-positive Sézary syndrome with a Th1 cytokine profile. , 1996, Journal of the American Academy of Dermatology.

[13]  M. Nikolova,et al.  Killer cell immunoglobulin‐like receptor expression delineates in situ Sézary syndrome lymphocytes , 2003, Journal of Pathology.

[14]  M. Polansky,et al.  Variable CD7 expression on T cells in the leukemic phase of cutaneous T cell lymphoma (Sézary syndrome). , 2001, The Journal of investigative dermatology.

[15]  R. Swerlick,et al.  HMEC-1: establishment of an immortalized human microvascular endothelial cell line. , 1992, The Journal of investigative dermatology.

[16]  R. Willemze,et al.  Aberrant Expression of the Tyrosine Kinase Receptor EphA4 and the Transcription Factor Twist in Sézary Syndrome Identified by Gene Expression Analysis , 2004, Cancer Research.

[17]  I. N. Reid,et al.  Enhanced expression of vimentin in motile prostate cell lines and in poorly differentiated and metastatic prostate carcinoma , 2002, The Prostate.

[18]  P. Nowell,et al.  BCL2 and JUNB abnormalities in primary cutaneous lymphomas , 2004, The British journal of dermatology.

[19]  R. Biassoni,et al.  CD4(+) cutaneous T-cell lymphoma cells express the p140-killer cell immunoglobulin-like receptor. , 2001, Blood.

[20]  D. Markovitz,et al.  Vimentin is secreted by activated macrophages , 2003, Nature Cell Biology.

[21]  R. Dummer,et al.  Genotypic, phenotypic and functional analysis of CD4+CD7+ and CD4+CD7– T lymphocyte subsets in Sézary syndrome , 1999, Archives of Dermatological Research.

[22]  D. Markovitz,et al.  The Endothelial Cell-Specific Antibody PAL-E Identifies a Secreted Form of Vimentin in the Blood Vasculature , 2004, Molecular and Cellular Biology.

[23]  M. Davison,et al.  α-actinins and the DMD protein contain spectrin-like repeats , 1988, Cell.

[24]  D. Schadendorf,et al.  SEREX identification of new tumour‐associated antigens in cutaneous T‐cell lymphoma , 2004, The British journal of dermatology.

[25]  M. Yacoub,et al.  Antigenic heterogeneity of vascular endothelium. , 1992, The American journal of pathology.

[26]  D. Ruiter,et al.  Monoclonal antibody PAL-E specific for endothelium. , 1985, Laboratory investigation; a journal of technical methods and pathology.

[27]  S. Meuer,et al.  Human T lymphocyte activation induces tyrosine phosphorylation of α‐tubulin and its association with the SH2 domain of the p59fyn protein tyrosine kinase , 1995, European journal of immunology.

[28]  A. Shevchenko,et al.  Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. , 1996, Analytical chemistry.

[29]  Z. Li,et al.  Cloning of a novel T-cell protein FYB that binds FYN and SH2-domain-containing leukocyte protein 76 and modulates interleukin 2 production. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[30]  B. Dörken,et al.  Identification of Apoptosis-associated Proteins in a Human Burkitt Lymphoma Cell Line , 1998, The Journal of Biological Chemistry.

[31]  A. de Matteis,et al.  The relevance of the CD4+ CD26– subset in the identification of circulating Sézary cells , 2001, The British journal of dermatology.

[32]  M J O'Hare,et al.  Humoral immunity to human breast cancer: antigen definition and quantitative analysis of mRNA expression. , 2001, Cancer immunity.

[33]  J. Jongstra,et al.  A new lymphocyte-specific gene which encodes a putative Ca2+-binding protein is not expressed in transformed T lymphocyte lines. , 1988, Journal of immunology.

[34]  P. Linsley,et al.  Lymphocyte activation: T-cell regulation by CTLA-4 , 1996, Current Biology.

[35]  M. Nikolova,et al.  Increased expression of a novel early activation surface membrane receptor in cutaneous T cell lymphoma cells. , 2001, The Journal of investigative dermatology.